PYRAZOLOBENZAMIDES AND DERIVATIVES AS FACTOR XA INHIBITORS
申请人:Bristol-Myers Squibb Company
公开号:EP1812403A2
公开(公告)日:2007-08-01
US7381732B2
申请人:——
公开号:US7381732B2
公开(公告)日:2008-06-03
[EN] PYRAZOLOBENZAMIDES AND DERIVATIVES AS FACTOR XA INHIBITORS<br/>[FR] PYRAZOLOBENZAMIDES ET LEURS DERIVES EN TANT QU'INHIBITEURS DU FACTEUR XA
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2006047528A2
公开(公告)日:2006-05-04
[EN] The present application describes pyrazolobenzamides and derivatives thereof of Formula (I), or pharmaceutically acceptable salt forms thereof. Compounds of the present invention are useful as inhibitors of trypsin-like serine proteases, specifically factor Xa. [FR] Pyrazolobenzamides et leurs dérivés de formule P4-P-M-M4, ou sels acceptables sur le plan pharmaceutique desdits composés. Les composés selon la présente invention sont utiles en tant qu'inhibiteurs de sérine-protéases de type trypsine, spécifiquement du facteur Xa.
Pyrazolobenzamides and derivatives as factor Xa inhibitors
申请人:Lam Y. Patrick
公开号:US20060089496A1
公开(公告)日:2006-04-27
The present application describes pyrazolobenzamides and derivatives thereof of Formula I:
P
4
-P-M-M
4
I
or pharmaceutically acceptable salt forms thereof. Compounds of the present invention are useful as inhibitors of trypsin-like serine proteases, specifically factor Xa.